A method of predicting the emergence and development of diabetic retinopathy in patients with insulin-dependent diabetes

摘要

1. method u043fu0440u043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 u0432u043eu0437u043du0438u043au043du043eu0432u0435u043du0438u00a0 and u043fu0440u043eu0433u0440u0435u0441u0441u0438u0440u043eu0432u0430u043du0438u00a0 diabetic retinopathy in patients with insulin dependent diabetes mellitus, including u0438u043cu043cu0443u043du043eu043bu043eu0433u0438u0447u0435u0441u043au043eu0435 study u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, in serum u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 content of interleukin - 1 and with its concentration in 50 ml and above an u0432u043eu0437u043du0438u043au043du043eu0432 kgp. by and / or progression of diabetic retinopathy.;2. method for item 1, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 because u0438u0437u0441u0434 patients without clinically u00a0u0432u043du044bu0445 changes at the bottom of the eye to predict in diabetic retinopathy u043du0446u0435u043du0442u0440u0430u0446u0438u0438 interleukin - 1 700 kgp / ml or more.